Sean Wharton
Eli Lilly (United States)
2 papers in the Anchorcite directory, published between 2021 and 2022, cited 10,084 times in total.
ORCID profileResearch topics
- Diabetes Treatment and Management · 2 papers
- Pharmacology and Obesity Treatment · 2 papers
- Regulation of Appetite and Obesity · 2 papers
Frequent co-authors
- John P.H. Wilding · 1 paper
- Rachel Louise Batterham · 1 paper
- Salvatore Calanna · 1 paper
- Melanie Jane Davies · 1 paper
- Luc F. Van Gaal · 1 paper
- Ildiko Lingvay · 1 paper
- Barbara M. McGowan · 1 paper
- Julio Rosenstock · 1 paper
Papers
- Once-Weekly Semaglutide in Adults with Overweight or ObesityNew England Journal of Medicine · 2021 · 5,804 citations
BACKGROUND: Obesity is a global health challenge with few pharmacologic options. Whether adults with obesity can achieve weight loss with once-weekly semaglutide at a dose of 2.4 mg as an adjunct to lifestyle intervention has not been confirmed. METHODS: In…
- Tirzepatide Once Weekly for the Treatment of ObesityNew England Journal of Medicine · 2022 · 4,280 citations
BACKGROUND: Obesity is a chronic disease that results in substantial global morbidity and mortality. The efficacy and safety of tirzepatide, a novel glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, in people with obesity are not known. METHODS: In this…
Metadata from OpenAlex (CC0).